Catalyst Wire Dossier Catalyst Wire Dossier

Fosnetupitant

fosnetupitant · Helsinn Healthcare SA
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Fosnetupitant, covering 2025-05-04 to 2025-05-04. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Trial to Assess Safety and Pharmacokinetics of Fosnetupitant 235 mg and Metabolites in Healthy Volunteers [Phase 1]

See pricing